Australia markets close in 43 minutes
  • ALL ORDS

    7,281.10
    +50.10 (+0.69%)
     
  • ASX 200

    7,023.10
    +46.20 (+0.66%)
     
  • AUD/USD

    0.7671
    +0.0024 (+0.31%)
     
  • OIL

    60.63
    +0.45 (+0.75%)
     
  • GOLD

    1,742.60
    -5.00 (-0.29%)
     
  • BTC-AUD

    83,765.20
    +4,415.20 (+5.56%)
     
  • CMC Crypto 200

    1,387.30
    +93.31 (+7.21%)
     
  • AUD/EUR

    0.6409
    +0.0014 (+0.21%)
     
  • AUD/NZD

    1.0811
    -0.0018 (-0.17%)
     
  • NZX 50

    12,751.38
    +94.98 (+0.75%)
     
  • NASDAQ

    13,986.49
    +167.09 (+1.21%)
     
  • FTSE

    6,890.49
    +1.37 (+0.02%)
     
  • Dow Jones

    33,677.27
    -68.13 (-0.20%)
     
  • DAX

    15,234.36
    +19.36 (+0.13%)
     
  • Hang Seng

    28,902.09
    +404.84 (+1.42%)
     
  • NIKKEI 225

    29,670.65
    +131.95 (+0.45%)
     

New Strong Sell Stocks for March 3rd

Zacks Equity Research
·1-min read

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

American Campus Communities, Inc. ACC owns, manages and develops high-quality student housing communities. The Zacks Consensus Estimate for its current year earnings has been revised 2.4% downward over the last 30 days.

GlaxoSmithKline plc GSK engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products. The Zacks Consensus Estimate for its current year earnings has been revised 6.2% downward over the last 30 days.

Identiv, Inc. INVE operates as a security technology company. The Zacks Consensus Estimate for its current year earnings has been revised 29.6% downward over the last 30 days.

Neptune Wellness Solutions Inc. NEPT operates as an integrated health and wellness company. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.

Oyster Point Pharma, Inc. OYST is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 7.2% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
GlaxoSmithKline plc (GSK) : Free Stock Analysis Report
 
American Campus Communities Inc (ACC) : Free Stock Analysis Report
 
Identiv, Inc. (INVE) : Free Stock Analysis Report
 
Neptune Wellness Solutions Inc. (NEPT) : Free Stock Analysis Report
 
OYSTER PT PHARM (OYST) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.